Using past BUD means accepting unknown potency and higher contamination risk
The older we get, the more likely we are to suffer from lower levels of semorelin and growth hormone, as the aging process has slowed down the bodys production of the hormone
The question is: Does this compound need the local concentration spike, or is systemic exposure enough
Step two: match the indication to the drug The four major GLP-1 medications have distinct FDA-approved indications, and insurance coverage tracks those indications closely
Methods Narrative review of mechanistic pathways and randomized trials of GLP-1 receptor agonists (GLP-1RA), DPP-4 inhibitors, and newer dual/triple agonists, with targeted updates from recent pivotal programs (SELECT, FLOW, SOUL, SURPASS-CVOT) and emerging oral small-molecule GLP-1R agonists